Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes
Objective: As gene-based therapies may soon arise for patients with spinocerebellar ataxia (SCA), there is a critical need to identify biomarkers of disease progression with effect sizes greater than clinical scores, enabling trials with smaller sample sizes. Methods: We enrolled a unique cohort of...
Main Authors: | Isaac M. Adanyeguh, Vincent Perlbarg, Pierre-Gilles Henry, Daisy Rinaldi, Elodie Petit, Romain Valabregue, Alexis Brice, Alexandra Durr, Fanny Mochel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | NeuroImage: Clinical |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158218301943 |
Similar Items
-
Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia
by: Giulia Coarelli, et al.
Published: (2021-06-01) -
Autosomal recessive cerebellar ataxias
by: Palau Francesc, et al.
Published: (2006-11-01) -
Autosomal dominant cerebellar ataxia type III: a review of the phenotypic and genotypic characteristics
by: Fujioka Shinsuke, et al.
Published: (2013-01-01) -
Autosomal dominant cerebellar ataxia type I: A review of the phenotypic and genotypic characteristics
by: Fujioka Shinsuke, et al.
Published: (2011-05-01) -
Molecular genetic study of autosomal dominant cerebellar ataxia in pedigrees from Cuba and Thailand
by: Twells, Rebecca Christina Joan
Published: (1995)